Cepheid (CPHD) Stock Price, News & Analysis

Company Overview

Cepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.

Key Stats

• Today's Range: $52.95 to $52.95
• 50-Day Range: N/A
• 52-Week Range: $25.09 to $53.91
• Volume: N/A
• Average Volume: 1.25 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CPHD Stock Analysis - Frequently Asked Questions

How were Cepheid's earnings last quarter?

Cepheid (NASDAQ:CPHD) released its quarterly earnings results on Thursday, July, 28th. The scientific and technical instruments company reported $0.05 EPS for the quarter, topping the consensus estimate of ($0.14) by $0.19. The company's revenue was up 10.2% compared to the same quarter last year.

What other stocks do shareholders of Cepheid own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cepheid investors own include Editas Medicine (EDIT), Nokia (NOK), Bristol Myers Squibb (BMY), GE Aerospace (GE), Gilead Sciences (GILD), QUALCOMM (QCOM) and AK Steel (AKS).

Company Calendar

• Last Earnings: 7/28/2016
• Today: 8/27/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: Biotechnology
• Current Symbol: NASDAQ:CPHD
• CIK: 1037760
• Web: www.cepheid.com
• Phone: +1-408-5414191
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A